Glenmark Pharma
GLENMARK Glenmark Pharma: Company gets US FDA’s ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution. (Positive)
Chart gives trendline breakout, momentum looking positive.
#Today’sTradingSetup#StockInNews#TechnicalViews#FundamentalViews#EquityResearch
170 likes·65 comments